Glenmark Pharmaceuticals Limited
GLENMARK · 532296 · Healthcare · Pharmaceuticals
- Market cap
- Rs 69,421 Cr
- P/E
- 38.61x
- P/B
- 6.60x
- 52W high / low
- Rs 2,537.6 / Rs 1,792.6
Our computed roe (15.46%) diverges from BSE's own published figure (-0.84%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed operating_margin (15.43%) diverges from BSE's own published figure (-1.37%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (10.14%) diverges from BSE's own published figure (-3.44%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Pharmaceuticals. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Sun Pharmaceutical Industries Limited | Rs 1,931.7 | Rs 4,63,473 Cr | Rs 62,141 Cr | Rs 12,117 Cr | 38.33x | 15.53% |
| Divi's Laboratories Limited | Rs 9,220 | Rs 2,44,330 Cr | Rs 11,682 Cr | Rs 2,925 Cr | 83.66x | 18.44% |
| Torrent Pharmaceuticals Limited | Rs 5,012 | Rs 1,69,636 Cr | Rs 15,654 Cr | Rs 2,156 Cr | 80.06x | 27.30% |
| Zydus Lifesciences Limited | Rs 1,154.2 | Rs 1,15,189 Cr | Rs 29,052 Cr | Rs 4,593 Cr | 25.72x | 17.68% |
| Cipla Limited | Rs 1,412.8 | Rs 1,14,133 Cr | Rs 29,159 Cr | Rs 3,356 Cr | 33.85x | 10.27% |
| Laurus Labs Limited | Rs 1,864 | Rs 1,00,703 Cr | Rs 7,323 Cr | Rs 1,091 Cr | 92.00x | 22.38% |
| Mankind Pharma Limited | Rs 2,391.5 | Rs 98,769 Cr | Rs 15,062 Cr | Rs 2,068 Cr | 48.32x | 13.50% |
| Lupin Limited | Rs 2,155.2 | Rs 98,547 Cr | Rs 30,442 Cr | Rs 5,551 Cr | 17.81x | 27.89% |
| Dr. Reddy's Laboratories Limited | Rs 1,156.5 | Rs 96,568 Cr | Rs 34,651 Cr | Rs 3,183 Cr | 29.89x | 9.02% |
| Aurobindo Pharma Limited | Rs 1,648.2 | Rs 94,837 Cr | Rs 35,625 Cr | Rs 3,711 Cr | 25.75x | 10.53% |
| Glenmark Pharmaceuticals LimitedThis company | Rs 2,460 | Rs 69,421 Cr | Rs 18,236 Cr | Rs 1,798 Cr | 38.61x | 15.46% |
| Biocon Limited | Rs 401 | Rs 65,347 Cr | Rs 17,638 Cr | Rs 416 Cr | — | 1.78% |
| Alkem Laboratories Limited | Rs 5,210 | Rs 62,286 Cr | Rs 15,681 Cr | Rs 2,204 Cr | 28.87x | 16.72% |
| Abbott India Limited | Rs 26,045 | Rs 55,346 Cr | Rs 7,295 Cr | Rs 1,615 Cr | 34.28x | 35.85% |
| GlaxoSmithKline Pharmaceuticals Limited | Rs 2,949.9 | Rs 49,974 Cr | Rs 4,100 Cr | Rs 1,068 Cr | 47.57x | 50.64% |
| Median | Rs 2,155.2 | Rs 98,769 Cr | Rs 15,681 Cr | Rs 2,925 Cr | 34.28x | 17.68% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.